Short answer
Prime Medicine, Inc. (PRME) filed an 8-K current report with the SEC on July 8, 2026 reporting Item 8.01 (Other Events). Arbitration victory confirms PM647 falls within Prime’s contractual “Field” for AATD treatment.
Prime Medicine, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 8.01 · Other Events
- Arbitration victory confirms PM647 falls within Prime’s contractual “Field” for AATD treatment
- Tribunal found no breach of the 2019 Beam collaboration and license agreement
- Beam’s damages and injunctive-relief requests denied, reducing immediate legal and development risk
- Remaining claims by Beam and Prime denied, leaving no additional relief disclosed in the award
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Prime Medicine, Inc. 8-K filings
Get the next PRME 8-K as it lands
Follow PRME for push alerts, or ask the research agent what this filing means.